Patents by Inventor Jean-Claude Pascal

Jean-Claude Pascal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8420632
    Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: April 16, 2013
    Assignee: Galderma Research & Developlment
    Inventors: Laurence Clary, Sandrine Chambon, Laurent Chantalat, Carine Rosignoli, Olivier Roye, Jean-Claude Pascal, Marléne Schuppli
  • Publication number: 20130079544
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, compounds having the general formula (I): are described. A process for preparing such compounds and their cosmetic or dermatological use are also described. The described compounds can act as bactericides. As a result, they can be useful in the treatment of conditions associated with the presence of bacteria, more specifically of P. acnes.
    Type: Application
    Filed: December 22, 2010
    Publication date: March 28, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Nicolas Rodeville, Jean-Claude Pascal, Claire Bouix-Peter
  • Patent number: 8404836
    Abstract: Novel 3-phenyl acrylic acid compounds have the following general formula (I): and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, as well as in the field of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or into cosmetic compositions.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: March 26, 2013
    Assignee: Galderma Research & Development
    Inventors: Jean-Guy Boiteau, Laurence Clary, Jean-Claude Pascal, Sandrine Chambon
  • Patent number: 8372879
    Abstract: 4-(heterocycloalkyl)benzene-1,3-diol compounds are described corresponding to general formula (I) below: Also described, are compositions including the same, processes for preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions for use in the treatment or prevention of pigmentary disorders.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: February 12, 2013
    Assignee: Galderma Research & Development
    Inventors: Jean-Guy Boiteau, Jean-Claude Pascal
  • Publication number: 20130022644
    Abstract: Compounds of general Formula (I), and cosmetic and pharmaceutical compositions including such a compound are described.
    Type: Application
    Filed: February 26, 2010
    Publication date: January 24, 2013
    Inventors: Jean-Claude Pascal, Cédric Poinsard
  • Publication number: 20120323035
    Abstract: Compounds of the following general formula (I): are described. Also described, are processes of their preparation and their use in therapeutic applications.
    Type: Application
    Filed: December 10, 2010
    Publication date: December 20, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Bouix-Peter, Jean-Claude Pascal, Nicolas Rodeville
  • Publication number: 20120323006
    Abstract: Benzenesulfonamide compounds having a structure of formula (I) are described. Also described, are methods for synthesizing the compounds and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
    Type: Application
    Filed: June 28, 2010
    Publication date: December 20, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Clary, Sandrine Chambon, Laurent Chantalat, Carine Rosignoli, Olivier Roye, Jean-Claude Pascal, Marlene Schuppli
  • Publication number: 20120226033
    Abstract: The present invention relates to novel benzene-carboxamide compounds having a structure that corresponds to the general formula (I) below: and also to their method of synthesis and to their use in pharmaceutical compositions intended for use in human or veterinary medicine or else to their use in cosmetic compositions.
    Type: Application
    Filed: September 16, 2010
    Publication date: September 6, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurence Clary, Jean-Claude Pascal
  • Publication number: 20120045500
    Abstract: Compounds of general formula (I): and cosmetic and pharmaceutical compositions including such a compound are described.
    Type: Application
    Filed: February 26, 2010
    Publication date: February 23, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Thibaud Portal, Jean-Claude Pascal
  • Publication number: 20120041213
    Abstract: 4-(heterocycloalkyl)benzene-1,3-diol compounds are described corresponding to general formula (I) below: Also described, are compositions including the same, processes for preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions for use in the treatment or prevention of pigmentary disorders.
    Type: Application
    Filed: December 2, 2009
    Publication date: February 16, 2012
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Guy Boiteau, Jean-Claude Pascal
  • Publication number: 20110274638
    Abstract: Compounds derived from oxoazetidine corresponding to general formula (I) compositions containing same, processes for their preparation and their use in pharmaceutical or cosmetic compositions are described.
    Type: Application
    Filed: November 4, 2009
    Publication date: November 10, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Nicolas Rodeville, Pascale Mauvais, Jean-Claude Pascal
  • Patent number: 7879907
    Abstract: Novel 3-phenylpropanoic acid compounds have the general formula (I) below: and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: December 7, 2009
    Date of Patent: February 1, 2011
    Assignee: Galderma Research & Development
    Inventors: Jean-Guy Boiteau, Laurence Clary, Jean-Claude Pascal, Veronique Parnet
  • Publication number: 20100158843
    Abstract: Novel 3-phenylpropanoic acid compounds have the general formula (I) below: and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or lipid metabolism-related diseases), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: December 7, 2009
    Publication date: June 24, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Guy BOITEAU, Laurence Clary, Jean-Claude Pascal, Veronique Parnet
  • Publication number: 20100145105
    Abstract: Vitamin D derivatives, notably non-steroidal vitamin D derivatives, are prepared from novel disubstituted phenylboronic acid compounds having the formula (I): and also from the novel intermediates having the formulae (1), (2), (3) and (10):
    Type: Application
    Filed: December 10, 2009
    Publication date: June 10, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Eric Terranova, Jean-Claude Pascal
  • Publication number: 20100144884
    Abstract: Novel 3-phenyl acrylic acid compounds have the following general formula (I): and are formulated into pharmaceutical compositions for administration in human or veterinary medicine (in dermatology, as well as in the field of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or into cosmetic compositions.
    Type: Application
    Filed: December 7, 2009
    Publication date: June 10, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Guy BOITEAU, Laurence CLARY, Jean-Claude PASCAL, Sandrine CHAMBON
  • Publication number: 20100087669
    Abstract: Vitamin D derivatives, notably non-steroidal vitamin D derivatives, are prepared from novel disubstituted phenylboronic acid compounds having the formula (I): and also from the novel intermediates having the formulae (1), (2), (3) and (10):
    Type: Application
    Filed: December 10, 2009
    Publication date: April 8, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Eric TERRANOVA, Jean-Claude Pascal
  • Patent number: 7659421
    Abstract: Vitamin D derivatives, notably non-steroidal vitamin D derivatives, are prepared from novel disubstituted phenylboronic acid compounds having the formula (I): and also from the novel intermediates having the formulae (1), (2), (3) and (10):
    Type: Grant
    Filed: June 19, 2006
    Date of Patent: February 9, 2010
    Assignee: Galderma Research & Development
    Inventors: Eric Terranova, Jean-Claude Pascal
  • Patent number: 7638657
    Abstract: 3-[5?-(3,4-bis(hydroxymethyl)benzyloxy)-2?-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol is prepared from the novel intermediate, 6-ethyl-4?-(1-ethyl-1-hydroxypropyl)-2?-propylbiphenyl-3-ol.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: December 29, 2009
    Assignee: Galderma Research & Development
    Inventors: Eric Terranova, Sebastien Daver, Christine Marty, Jean-Claude Pascal
  • Patent number: 7498461
    Abstract: A novel method for preparing 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid includes a Suzuki reaction between 3-adamantyl-4-methoxyphenylboronic acid of formula (II): and 6-bromo-2-naphthoic acid of formula (III):
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: March 3, 2009
    Assignee: Galderma Research & Development
    Inventors: Eric Terranova, Jean-Claude Pascal
  • Publication number: 20080091045
    Abstract: A novel method for preparing 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid includes a Suzuki reaction between 3-adamantyl-4-methoxyphenylboronic acid of formula (II): and 6-bromo-2-naphthoic acid of formula (III):
    Type: Application
    Filed: October 5, 2007
    Publication date: April 17, 2008
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Eric Terranova, Jean-Claude Pascal